Belviq and Belviq XR are weight-loss medications that help people who are struggling with obesity. These prescription drugs are supposed to give users a “full” feeling while they’re on a low-calorie diet. The U.S. Food and Drug Administration (FDA) approved this medication in 2012 and required Eisai, the drug company, to conduct clinical trials to determine its safety and efficacy. The FDA expressed concerns over the trial data they received, as the drug has now reportedly been linked to a variety of cancers.
Law firms can connect with victims who have developed cancer because of Belviq by contacting Broughton Partners, a legal marketing firm that provides attorneys with qualified Belviq claimants. Patients who have suffered harmful side effects after taking Belviq will be looking for a drug injury law firm for legal assistance. Broughton Partners connects personal injury law firms with retained Belviq plaintiffs and other drug injury victims. The retained plaintiffs we deliver to law firms are case-ready and pre-qualified.